Search for: "Keys v. Target Corporation" Results 41 - 60 of 982
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jan 2024, 9:01 pm by renholding
Key Points Despite the odd procedural posture, this was an important, novel ruling on an issue of significance for corporate practitioners. [read post]
2 Jan 2012, 2:31 pm by Francis Pileggi
Introduction This is the seventh year that we are providing an annual review of key Delaware corporate and commercial decisions. [read post]
27 Mar 2019, 3:24 am by Matrix Legal Support Service
The Supreme Court concluded that, in the present dispute, the balance or symmetry in patent law and the pre-established or at least readily foreseeable target of the skilled team’s tests hold the key to its resolution. [read post]
3 Mar 2011, 9:19 am by Calvin Massey
Only Justice Alito, in his dissent, discussed the later web posting by the Westboro defendants, which consisted of a diatribe concerning how the parents of deceased Corporal Snyder had raised their son. [read post]
12 May 2018, 9:11 am
This symposium explores these and other issues.Keynote Lecture: James V Feinerman, Associate Dean for Transnational Programs, Co-Director, Georgetown Law Asia, and James M. [read post]
30 Dec 2011, 5:17 pm by Eugene Volokh
(Eugene Volokh) In today’s Western Tradition Partnership, Inc. v. [read post]
3 May 2018, 3:44 am by John Buhl
These provisions are targeted at high-return foreign profits, intangible income, and income stripped out of the United States. [read post]
21 Jun 2020, 5:52 pm by Francis Pileggi
The Chancery Court recently green-lighted key parts of an investment company’s suit against officers and owners who allegedly inflated their I.T. and data center services provider’s worth, finding the buyer plaintiff was more likely the victim of fraud and breach of contract rather than mere buyer’s remorse in LightEdge Holdings LLC, et al. v. [read post]
27 Jul 2011, 1:01 am by Marie Louise
  Highlights this week included: Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v.… [read post]
4 Jan 2024, 3:15 am by Liz Dunshee
In an August webcast on this site and PracticalESG.com, legal & DEI experts joined us to explain what leaders of corporate DEI programs should be doing following the June SCOTUS decision in Students for Fair Admissions v. [read post]
9 Feb 2023, 9:05 pm by renholding
Following another year of increasing focus on environmental, social and governance (ESG) considerations by companies, investors and regulators alike, ESG appears to have cemented its position in the corporate landscape. [read post]